Amneal Pharmaceuticals (NYSE:AMRX) Stock In Focus After The Recent Slump

November 22, 2021

Shares of Amneal Pharmaceuticals (NYSE:AMRX) have been under selling pressure over the past month with  fall of 18%. Trading Data On Friday, AMRX stock gained 0.65% to $4.62 with 745k shares, compared to its average volume of 1.03 million shares. The stock has moved within a range of $4.5300 – 4.7150 after opening trade at $4.53. FDA Approves Difluprednate Ophthalmic Emulsion by Amneal Pharmaceuticals Amneal Pharmaceuticals (NYSE:AMRX) announced on November…